Literature DB >> 29147625

A transcriptomic insight into the impacts of mast cells in lung, breast, and colon cancers.

Eun-A Ko1, Kenton M Sanders1, Tong Zhou1.   

Abstract

To date, the exact impact of mast cells in tumor microenvironment is still controversial because of inconsistency in observations regarding the relationship between mast cell infiltrates and cancer development and prognosis. The discrepancies in previous studies have motivated us to examine the roles of mast cells in cancer pathology from different perspectives. Here, we investigated the impact of mast cells on transcriptomic profiles in the tissue microenvironment. Mice carrying the W-sh mutation in c-kit (KitW-sh ) are deficient in mast cell production and were used to assess the influence of mast cells on gene expression. By examining the transcriptomic profile among wild-type mice, KitW-sh mice, and KitW-sh mice with mast cell engraftment, we identified a list of "mast cell-dependent genes," which are enriched for cancer-related pathways. Utilizing whole-genome gene expression data from both mouse models and human cancer patients, we demonstrated that the expression profile of the mast cell-dependent genes differs between tumor and normal tissues from lung, breast, and colon, respectively. Mast cell infiltration is potentially increased in tumors compared with normal tissues, suggesting that mast cells might participate in tumor development. Accordingly, a prognostic molecular signature was developed based on the mast cell-dependent genes, which predicted recurrence-free survival for human patients with lung, breast, and colon cancers, respectively. Our study provides a novel transcriptomic insight into the impact of mast cells in the tumor microenvironment, though further experimental investigation is needed to validate the exact role of individual mast cell-dependent genes in different cancers.

Entities:  

Keywords:  breast cancer; colon cancer; gene expression; lung cancer; mast cell

Year:  2017        PMID: 29147625      PMCID: PMC5674965          DOI: 10.1080/2162402X.2017.1360457

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  84 in total

Review 1.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

2.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

3.  Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.

Authors:  C A Derosa; B Furusato; S Shaheduzzaman; V Srikantan; Z Wang; Y Chen; M Seifert; M Siefert; L Ravindranath; D Young; M Nau; A Dobi; T Werner; D G McLeod; M T Vahey; I A Sesterhenn; S Srivastava; G Petrovics
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-11-29       Impact factor: 5.554

4.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

Authors:  Tomas J Welsh; Ruth H Green; Donna Richardson; David A Waller; Kenneth J O'Byrne; Peter Bradding
Journal:  J Clin Oncol       Date:  2005-10-11       Impact factor: 44.544

5.  Dual role of TGFBR3 in bladder cancer.

Authors:  Xiao-Long Liu; Kebing Xiao; Boxin Xue; Dongrong Yang; Zhe Lei; Yuxi Shan; Hong-Tao Zhang
Journal:  Oncol Rep       Date:  2013-07-08       Impact factor: 3.906

6.  DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.

Authors:  Xia Jiang; Jing Tan; Jingsong Li; Saul Kivimäe; Xiaojing Yang; Li Zhuang; Puay Leng Lee; Mark T W Chan; Lawrence W Stanton; Edison T Liu; Benjamin N R Cheyette; Qiang Yu
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743

7.  The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.

Authors:  Yang Wang; Dan Chen; Haili Qian; Yihsuan S Tsai; Shujuan Shao; Quentin Liu; Daniel Dominguez; Zefeng Wang
Journal:  Cancer Cell       Date:  2014-09-08       Impact factor: 31.743

8.  PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.

Authors:  Puxiongzhi Wang; Jingkun Zhao; Xiao Yang; Shaopei Guan; Hao Feng; Dingpei Han; Jun Lu; Baochi Ou; Runsen Jin; Jing Sun; Yaping Zong; Bo Feng; Junjun Ma; Aiguo Lu; Minhua Zheng
Journal:  Med Oncol       Date:  2015-11-09       Impact factor: 3.064

Review 9.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

10.  Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.

Authors:  Josef Mang; Nina Korzeniewski; Dimo Dietrich; Verena Sailer; Yanis Tolstov; Sam Searcy; Jost von Hardenberg; Sven Perner; Glen Kristiansen; Alexander Marx; Wilfried Roth; Esther Herpel; Carsten Grüllich; Valentin Popeneciu; Sascha Pahernik; Boris Hadaschik; Markus Hohenfellner; Stefan Duensing
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

View more
  3 in total

Review 1.  The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses.

Authors:  Reyes Gamez-Belmonte; Lena Erkert; Stefan Wirtz; Christoph Becker
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

2.  Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.

Authors:  Yingxin Yu; Bart R J Blokhuis; Mara A P Diks; Ali Keshavarzian; Johan Garssen; Frank A Redegeld
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

3.  Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation-the mast cell is an indicator of myeloid transformation.

Authors:  Peipei Xu; Cuiling Zhang; Yushan Wang; Hongyan Wu; Shuwen Cheng; Xiangshan Fan; Qiguo Zhang
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.